HUTCHMED (China) Limited ADR (HCM): Next-Year EPS Estimate 38.76%
As of 2026-06-11, HUTCHMED (China) Limited ADR (HCM) has a next-year EPS growth estimate of 38.76%.
On 2026-06-10, analyst consensus for HCM's next-year EPS growth shifted from 40.47% to 38.76% — a negative change of 1.71 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at -87.69%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 38.76%
- EPS growth this year
- -87.69%
- EPS next quarter (est)
- N/A
- Last price
- $10.68
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 38.76% | -87.69% | N/A | $10.68 |
| 2026-06-10 | 38.76% | -87.69% | N/A | $10.87 |
| 2026-06-09 | 40.47% | -87.66% | N/A | $10.63 |
| 2026-06-08 | 40.47% | -87.66% | N/A | $10.85 |
| 2026-06-07 | 40.47% | -87.66% | N/A | $10.87 |
| 2026-06-04 | 40.47% | -87.66% | N/A | $11.17 |
| 2026-06-03 | 40.47% | -87.66% | N/A | $11.31 |
| 2026-06-02 | 40.47% | -87.66% | N/A | $11.52 |
| 2026-06-01 | 40.47% | -87.66% | N/A | $11.40 |
| 2026-05-31 | 40.47% | -87.66% | N/A | $11.45 |
| 2026-05-28 | 44.07% | -87.71% | N/A | $11.23 |
| 2026-05-27 | 44.07% | -87.71% | N/A | $11.72 |
| 2026-05-26 | 44.07% | -87.71% | N/A | $11.75 |
| 2026-05-25 | 44.07% | -87.71% | N/A | $11.99 |
| 2026-05-24 | 44.07% | -87.71% | N/A | $11.99 |
| 2026-05-21 | 44.07% | -87.71% | N/A | $12.04 |
| 2026-05-20 | 44.07% | -87.71% | N/A | $11.91 |
| 2026-05-19 | 44.07% | -87.71% | N/A | $12.06 |
| 2026-05-18 | 44.07% | -87.71% | N/A | $11.95 |
| 2026-05-17 | 44.07% | -87.71% | N/A | $12.51 |
| 2026-05-14 | 44.07% | -87.71% | N/A | $12.69 |
| 2026-05-13 | 44.07% | -87.71% | N/A | $12.72 |
| 2026-05-12 | 44.07% | -87.71% | N/A | $12.67 |
| 2026-05-11 | 44.07% | -87.71% | N/A | $12.87 |
| 2026-05-10 | 44.07% | -87.71% | N/A | $13.13 |
| 2026-05-07 | 44.07% | -87.71% | N/A | $13.31 |
| 2026-05-06 | 44.07% | -87.71% | N/A | $13.43 |
| 2026-05-05 | 44.07% | -87.71% | N/A | $13.30 |
| 2026-05-04 | 44.07% | -87.71% | N/A | $13.22 |
| 2026-05-03 | 44.07% | -87.71% | N/A | $13.30 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is HUTCHMED (China) Limited ADR's next-year EPS growth estimate?▾
As of 2026-06-11, HUTCHMED (China) Limited ADR (HCM) has a next-year EPS growth estimate of 38.76%, based on analyst consensus.
When was the latest EPS estimate revision for HCM?▾
The most recent revision occurred on 2026-06-10, when analysts adjusted the next-year EPS growth estimate from 40.47% to 38.76%.
What sector and industry does HUTCHMED (China) Limited ADR belong to?▾
HUTCHMED (China) Limited ADR operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. HCM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. HUTCHMED (China) Limited ADR (HCM) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports